Inventor · disambiguated record
Gregory L. Mcintire
Also filed as: MCINTIRE GREGORY · MCINTIRE GREGORY L · MCINTIRE GREGORY LYNN
31 granted patents·23 pending applications·3,016 citations·filing 1992–2017
98Inventor score
Top patents by PatentIndex Score
54 records- 0198US5560932AMicroprecipitation of nanoparticulate pharmaceutical agentsNANO SYS LLC·Filed 1995·Granted Oct 1, 1996·350 cites·55 claims
- 0297US5662883AMicroprecipitation of micro-nanoparticulate pharmaceutical agentsNANOSYSTEMS LLC·Filed 1995·Granted Sep 2, 1997·376 cites·53 claims
- 0397US5569448ASulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositionsNANO SYS LLC·Filed 1995·Granted Oct 29, 1996·338 cites·5 claims
- 0496US6540981B2Light imaging contrast agentsAMERSHAM HEALTH AS·Filed 2000·Granted Apr 1, 2003·120 cites·31 claims
- 0596US5318767AX-ray contrast compositions useful in medical imagingSTERLING WINTHROP INC·Filed 1992·Granted Jun 7, 1994·291 cites·28 claims
- 0695US6159445ALight imaging contrast agentsNYCOMED IMAGING AS·Filed 1997·Granted Dec 12, 2000·365 cites·23 claims
- 0795US5451393AX-ray contrast compositions useful in medical imagingEASTMAN KODAK CO·Filed 1994·Granted Sep 19, 1995·171 cites·21 claims
- 0895US5352459AUse of purified surface modifiers to prevent particle aggregation during sterilizationSTERLING WINTHROP INC·Filed 1992·Granted Oct 4, 1994·274 cites·9 claims
- 0993US5401492AWater insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agentsSTERLING WINTHROP INC·Filed 1992·Granted Mar 28, 1995·168 cites·7 claims
- 1091US5716642AMicroprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agentsNANO SYS LLC·Filed 1995·Granted Feb 10, 1998·163 cites·30 claims
- 1190US6632176B2Products and methods for brachytherapyAMERSHAM PLC·Filed 2001·Granted Oct 14, 2003·72 cites·10 claims
- 1287US7014839B2Light imaging contrast agentsAMERSHAM HEALTH AS·Filed 2002·Granted Mar 21, 2006·22 cites·9 claims
- 1383US6662040B1Methods of photoacoustic imagingAMERSHAM HEALTH AS·Filed 1999·Granted Dec 9, 2003·74 cites·48 claims
- 1482US8637514B2Polymorphs of brimonidine pamoateBAUSCH & LOMB·Filed 2013·Granted Jan 28, 2014·2 cites·5 claims
- 1572US6423296B1Constrast mediaAMERSHAM HEALTH AS·Filed 1997·Granted Jul 23, 2002·50 cites·13 claims
- 1668US8034813B2Polymorphs of brimonidine pamoateBAUSCH & LOMB·Filed 2009·Granted Oct 11, 2011·0 cites·4 claims
- 1765US8637515B2Polymorphs of brimonidine pamoateBAUSCH & LOMB·Filed 2013·Granted Jan 28, 2014·0 cites·5 claims
- 1864US9170264B2Methods of monitoring for adherence to aripiprazole therapyAMERITOX LTD·Filed 2014·Granted Oct 27, 2015·1 cites·35 claims
- 1964US5346688AIodinated wetting agentsSTERLING WINTHROP INC·Filed 1992·Granted Sep 13, 1994·7 cites·5 claims
- 2063US6689043B1Products and methods for brachytherapyAMERSHAM PLC·Filed 1999·Granted Feb 10, 2004·87 cites·5 claims
- 2158US2010104551A1Method for prolonging activity of autodegradable enzymes and compositions thereofTALECRIS BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2257US2007128182A1Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular ConditionsBARTELS STEPHEN P·Filed 2007·Application pending·0 cites
- 2357US2008008698A1Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular ConditionsBARTELS STEPHEN P·Filed 2007·Application pending·0 cites
- 2457US2007141043A1Non-Surgical Method for Preventing or Reducing the Rate of the Progression of Non-Proliferative Diabetic Retinopathy and the Treatment of Other Ocular ConditionsBARTELS STEPHEN P·Filed 2007·Application pending·0 cites
- 2555US8420648B2Polymorphs of brimonidine pamoateWANG HONGNA·Filed 2011·Granted Apr 16, 2013·0 cites·5 claims
- 2654US2006257391A1Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditionsBAUSCH & LOMB·Filed 2005·Application pending·0 cites
- 2753US2008293728A1Complexes Comprising alpha2-Adrenergic Receptor Agonists and CompositionsMCINTIRE GREGORY L·Filed 2008·Application pending·0 cites
- 2852US7011619B1Apparatus and methods for radiotherapyGE HEALTHCARE LTD·Filed 1999·Granted Mar 14, 2006·56 cites·25 claims
- 2952US2006293378A1Method of lowering intraocular pressureMCINTIRE GREGORY·Filed 2006·Application pending·0 cites
- 3051US5472682ACompositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tractSTERLING WINTHROP INC·Filed 1994·Granted Dec 5, 1995·4 cites·24 claims
- 3151US5360604AX-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable claysSTERLING WINTHROP INC·Filed 1994·Granted Nov 1, 1994·15 cites·20 claims
- 3251US2005265923A1Embolus therapy using insoluble microparticles or vesicles containing contrast agentsTONER JOHN L·Filed 2005·Application pending·0 cites
- 3349US9606132B2Methods of monitoring adherence to lurasidone therapyAMERITOX LTD·Filed 2014·Granted Mar 28, 2017·0 cites·17 claims
- 3449US2007134231A1Method for prolonging activity of autodegradable enzymes and compositions thereofJANI DHARMENDRA M·Filed 2006·Application pending·0 cites
- 3549US2016003800A1Methods of monitoring for adherence to aripiprazole therapyAMERITOX LTD·Filed 2015·Application pending·0 cites
- 3647US2011183946A1Complexes Comprising alpha2-Adrenergic Receptor Agonists and Methods of Providing Neuroprotection or Treating or Inhibiting Progression of GlaucomaMCINTIRE GREGORY L·Filed 2011·Application pending·0 cites
- 3744US2017356923A1Methods of monitoring adherence to quetiapine therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 3841US2006199991A1Apparatus and methods for radiotherapyLEWIS DEWI M·Filed 2006·Application pending·0 cites
- 3941US2016041192A1Methods of monitoring adherence to quetiapine therapyAMERITOX LTD·Filed 2015·Application pending·0 cites
- 4040US6596097B1Method of coating a metal substrate with a radioactive layerAMERSHAM PLC·Filed 2000·Granted Jul 22, 2003·0 cites·17 claims
- 4140US5492687ACompositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tractSTERLING WINTHROP INC·Filed 1994·Granted Feb 20, 1996·7 cites·22 claims
- 4240US2017299574A1Methods of monitoring for adherence to aripiprazole therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 4339US2004047804A1Enhanced radiation therapyGEN HOSPITAL CORP·Filed 2003·Application pending·0 cites
- 4437US2017192025A1Methods of monitoring adherence to lurasidone therapyAMERITOX LLC·Filed 2017·Application pending·0 cites
- 4533US5484585ACompositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tractSTERLING WINTHROP INC·Filed 1994·Granted Jan 16, 1996·2 cites·20 claims
- 4631US2016300038A1Methods of normalizing measured drug concentrations in urine using patient specific data and testing for potential non-compliance with a chronic drug treatment regimenAMERITOX LTD·Filed 2016·Application pending·0 cites
- 4730US5531979ACompositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tractSTERLING WINTHROP INC·Filed 1994·Granted Jul 2, 1996·0 cites·32 claims
- 4830US5476646AX-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable claysSTERLING WINTHROP INC·Filed 1994·Granted Dec 19, 1995·0 cites·20 claims
- 4930US2016041146A1Methods of normalizing the ratio of measured parent and metabolite drug concentrations in fluids and testing for non-complianceAMERITOX LTD·Filed 2015·Application pending·0 cites
- 5030US2017029866A1Methods of monitoring adherence to haloperidol therapyAMERITOX LTD·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →